Latanoprost + Timolol Comp. Abz (Timolol Maleate, Latanoprost)

Latanoprost increases the outflow of aqueous humor through the uveoscleral pathway by activating prostaglandin F receptors. Timolol maleate reduces the production of aqueous humor by blocking β‑adrenergic receptors in the ciliary body. Together they provide a complementary reduction in eye pressure.

The dosing regimen for Latanoprost + Timolol is determined by the prescribing clinician based on the patient’s condition, response, and tolerance. Typically, one drop is instilled in the affected eye(s) once daily, but the exact dose and timing should follow the prescriber’s instructions.

Safety data for use in pregnancy or lactation are limited. The product should be used only if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should discuss individual circumstances and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with monotherapy, the latanoprost‑timolol combo offers dual mechanisms—enhanced outflow and reduced production—often achieving greater intra‑ocular pressure reduction. It may reduce the need for multiple separate eye drops, improving adherence, but individual response and tolerance should be evaluated against other options.

Latanoprost + Timolol should be stored at room temperature, below 25 °C. Keep the bottle tightly closed, protect it from light, and store it in the original packaging to avoid moisture exposure. Do not freeze the product.

The medication is applied as an ophthalmic solution. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place a single drop into the conjunctival sac of the prescribed eye(s). Close the eye gently and avoid blinking excessively for a few seconds.

Serious risks include severe allergic reactions, marked bradycardia or heart block, bronchospasm in susceptible individuals, and significant drops in systemic blood pressure. Patients should be instructed to seek immediate medical attention if they experience symptoms such as difficulty breathing, fainting, or rapid heartbeat.

The product should be avoided in patients with known hypersensitivity to latanoprost, timolol, or any excipients, as well as those with severe asthma, chronic obstructive pulmonary disease, sinus bradycardia, second‑ or third‑degree heart block, or uncontrolled heart failure unless specifically directed by a physician.